Loading...
Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.
Cannon, Jennifer S. ; Nicholas, John ; Orenstein, Jan M. ; Mann, Risa B. ; Murray, Paul G. ; Browning, Philip J. ; DiGiuseppe, Joseph A. ; Cesarman, Ethel ; Hayward, Gary S. ; Ambinder, Richard F.
Cannon, Jennifer S.
Nicholas, John
Orenstein, Jan M.
Mann, Risa B.
Murray, Paul G.
Browning, Philip J.
DiGiuseppe, Joseph A.
Cesarman, Ethel
Hayward, Gary S.
Ambinder, Richard F.
Editors
Other contributors
Affiliation
Epub Date
Issue Date
1999
Submitted date
2007-01-19
Alternative
Abstract
In order to characterize the expression of the viral interleukin-6 (vIL-6) homologue in various human herpesvirus 8 (HHV-8)-associated diseases, in situ hybridization and immunohistochemistry were applied to formalin-fixed specimens. These assays showed consistent expression of vIL-6 in primary effusion lymphomas and in a case of human immunodeficiency virus (HIV)-associated lymphadenopathy with a Castleman's disease-like appearance. In contrast, Kaposi's sarcoma specimens showed marked differences among specimens. In a consecutive series of specimens from the Johns Hopkins archives, vIL-6 expression was demonstrated in one of 13 cases. However, among 7 specimens selected from the AIDS Malignancy Bank because of their high levels of the T1.1 lytic transcript and virion production, vIL-6 expression was consistently demonstrated in infiltrating mononuclear cells and occasional spindle-shaped cells. Thus vIL-6 expression in clinical specimens correlates with other measures of the lytic viral cycle. Both assays generally give congruent results and are consistent with the possibility that vIL-6 expression plays a role in the pathogenesis of a variety of HHV-8-associated diseases.
Citation
Journal of Infectious Diseases, 180(3): 824-828
Publisher
Journal
Research Unit
DOI
PubMed ID
10438372
PubMed Central ID
Embedded videos
Type
Journal article
Language
en
Description
Series/Report no.
ISSN
0022-1899